SGLT2 inhibitors & GLP-1 analogues in the management of type 2 diabetes and cardio-renal disease

The Hatter Cardiovascular Institute, UCL Webinar Series for Nephrology Trainees

The Discussion Continues… SpR Views:

24th September 2021 (12 noon)

 

FREE TO ATTEND

https://ucl.zoom.us/meeting/register/tJ0odeqhpzsiGtVqtsVuIjWJq8SlrqfoJTPU

 

1.Emerging therapies affecting cardiovascular, renal and metabolic medicine?

Prof Mansoor Husain, University of Toronto, Toronto, Canada

 

2. SpR Case presentations: Out of my comfort zone!

 

(i) Cardiovascular – Dr Ali Rauf, Cardiology SpR

How do I handle a patient with renal/diabetic co-morbidities?

(ii) Renal – Dr Tamer Rezk, Nephrology SpR

How do I handle a patient with cardiac/diabetic co-morbidities?

(iii) Metabolic – Dr Eleni Armeni, Diabetes and Endocrinology SpR

How do I handle a patient with cardiac/renal co-morbidities?

 

3. Breakout Discussions by Trainees

 

When
September 24th, 2021 from 12:00 PM to  5:00 PM

Guidelines

NICE accredited clinical practice guidelines 

Available here

25th Annual Report

Analyses about the care provided to patients at UK renal centres.

Read the report

2022 UKRR AKI Report

A report on the nationwide collection of AKI warning test scores. 

Read the report